Literature DB >> 26735397

Treating trisomies: Prenatal Down's syndrome therapies explored in mice.

Bridget M Kuehn.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26735397     DOI： 10.1038/nm0116-6

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  12 in total

1.  Fetuses with Down syndrome have disproportionately shortened frontal lobe dimensions on ultrasonographic examination.

Authors:  R O Bahado-Singh; L Wyse; M A Dorr; J A Copel; T O'Connor; J C Hobbins
Journal:  Am J Obstet Gynecol       Date:  1992-10       Impact factor: 8.661

2.  Perinatal choline supplementation improves cognitive functioning and emotion regulation in the Ts65Dn mouse model of Down syndrome.

Authors:  Jisook Moon; May Chen; Shruti U Gandhy; Myla Strawderman; David A Levitsky; Kenneth N Maclean; Barbara J Strupp
Journal:  Behav Neurosci       Date:  2010-06       Impact factor: 1.912

Review 3.  From prenatal genomic diagnosis to fetal personalized medicine: progress and challenges.

Authors:  Diana W Bianchi
Journal:  Nat Med       Date:  2012-07-06       Impact factor: 53.440

4.  Synaptic structural abnormalities in the Ts65Dn mouse model of Down Syndrome.

Authors:  Pavel V Belichenko; Eliezer Masliah; Alexander M Kleschevnikov; Angela J Villar; Charles J Epstein; Ahmad Salehi; William C Mobley
Journal:  J Comp Neurol       Date:  2004-12-13       Impact factor: 3.215

5.  Prenatal pharmacotherapy rescues brain development in a Down's syndrome mouse model.

Authors:  Sandra Guidi; Fiorenza Stagni; Patrizia Bianchi; Elisabetta Ciani; Andrea Giacomini; Marianna De Franceschi; Randal Moldrich; Nyoman Kurniawan; Karine Mardon; Alessandro Giuliani; Laura Calzà; Renata Bartesaghi
Journal:  Brain       Date:  2013-12-12       Impact factor: 13.501

6.  New Perspectives for the Rescue of Cognitive Disability in Down Syndrome.

Authors:  Renata Bartesaghi; Tarik F Haydar; Jean Maurice Delabar; Mara Dierssen; Carmen Martínez-Cué; Diana W Bianchi
Journal:  J Neurosci       Date:  2015-10-14       Impact factor: 6.167

7.  Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus.

Authors:  J E Malberg; A J Eisch; E J Nestler; R S Duman
Journal:  J Neurosci       Date:  2000-12-15       Impact factor: 6.167

8.  A mouse model for Down syndrome exhibits learning and behaviour deficits.

Authors:  R H Reeves; N G Irving; T H Moran; A Wohn; C Kitt; S S Sisodia; C Schmidt; R T Bronson; M T Davisson
Journal:  Nat Genet       Date:  1995-10       Impact factor: 38.330

9.  Epigallocatechin-3-gallate, a DYRK1A inhibitor, rescues cognitive deficits in Down syndrome mouse models and in humans.

Authors:  Rafael De la Torre; Susana De Sola; Meritxell Pons; Arnaud Duchon; María Martínez de Lagran; Magí Farré; Montserrat Fitó; Bessy Benejam; Klaus Langohr; Joan Rodriguez; Mitona Pujadas; Jean Charles Bizot; Aída Cuenca; Nathalie Janel; Silvina Catuara; Maria Isabel Covas; Henri Blehaut; Yann Herault; Jean Marie Delabar; Mara Dierssen
Journal:  Mol Nutr Food Res       Date:  2013-09-14       Impact factor: 5.914

Review 10.  Specific SSRIs and birth defects: Bayesian analysis to interpret new data in the context of previous reports.

Authors:  Jennita Reefhuis; Owen Devine; Jan M Friedman; Carol Louik; Margaret A Honein
Journal:  BMJ       Date:  2015-07-08
View more
  3 in total

Review 1.  Mouse models of Down syndrome: gene content and consequences.

Authors:  Meenal Gupta; A Ranjitha Dhanasekaran; Katheleen J Gardiner
Journal:  Mamm Genome       Date:  2016-08-18       Impact factor: 2.957

2.  Prenatal and Postnatal Therapies for Down's Syndrome and Associated Developmental Anomalies and Degenerative Deficits: A Systematic Review of Guidelines and Trials.

Authors:  Zinnat Hasina; Chi Chiu Wang
Journal:  Front Med (Lausanne)       Date:  2022-07-05

3.  Early neurotrophic pharmacotherapy rescues developmental delay and Alzheimer's-like memory deficits in the Ts65Dn mouse model of Down syndrome.

Authors:  Syed Faraz Kazim; Julie Blanchard; Riccardo Bianchi; Khalid Iqbal
Journal:  Sci Rep       Date:  2017-04-03       Impact factor: 4.379
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.